Point-of-Care Magnetic Resonance Technology to Measure Biomarkers of Liver Disease

Motivation: MRI stands as the gold standard for diagnosing liver diseases. Ensuring widespread access to this technology is of critical importance to combat the prevalence of liver disease. Goal(s): Our goal is to decrease the prevalence of liver disease by making the diagnostic precision of MRI broadly available. Approach: We present a compact and open Magnetic Resonance device that employs the gold standard principles of MRI to accurately measure liver disease biomarkers. Results: The accuracy of Proton Density Fat Fraction is shown in recent clinical studies using a point-of-care non-imaging magnetic resonance device. Impact: The development and implementation of a portable, cost-effective device for liver disease diagnosis can transform clinical care, improve diagnosis efficiency, and address health disparities. The technology may enhance global research and facilitate treatment monitoring and earlier intervention.